| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vibrio cholerae | 138 | 2022 | 806 | 24.110 |
Why?
|
| Cholera | 42 | 2022 | 785 | 7.520 |
Why?
|
| Bacterial Proteins | 76 | 2023 | 3843 | 7.110 |
Why?
|
| Chromosomes, Bacterial | 32 | 2017 | 282 | 5.960 |
Why?
|
| Escherichia coli Infections | 27 | 2024 | 532 | 5.880 |
Why?
|
| DNA Transposable Elements | 27 | 2019 | 748 | 5.840 |
Why?
|
| Gene Expression Regulation, Bacterial | 53 | 2021 | 1119 | 5.400 |
Why?
|
| Vibrio parahaemolyticus | 14 | 2021 | 39 | 4.450 |
Why?
|
| Virulence Factors | 24 | 2023 | 509 | 4.350 |
Why?
|
| Conjugation, Genetic | 24 | 2010 | 126 | 4.300 |
Why?
|
| Cholera Vaccines | 11 | 2022 | 268 | 3.960 |
Why?
|
| Genome, Bacterial | 27 | 2019 | 754 | 3.710 |
Why?
|
| Virulence | 46 | 2023 | 1328 | 3.630 |
Why?
|
| Plasmids | 32 | 2019 | 2305 | 3.560 |
Why?
|
| Cholera Toxin | 26 | 2022 | 553 | 3.430 |
Why?
|
| Bacteriophages | 27 | 2012 | 354 | 3.300 |
Why?
|
| DNA, Bacterial | 29 | 2016 | 1465 | 3.240 |
Why?
|
| Genes, Bacterial | 30 | 2016 | 1078 | 3.130 |
Why?
|
| Intestines | 29 | 2021 | 1923 | 3.090 |
Why?
|
| Host-Pathogen Interactions | 20 | 2021 | 1477 | 2.760 |
Why?
|
| Bacteria | 18 | 2023 | 2102 | 2.720 |
Why?
|
| Escherichia coli O157 | 15 | 2019 | 54 | 2.680 |
Why?
|
| Enterohemorrhagic Escherichia coli | 9 | 2021 | 20 | 2.670 |
Why?
|
| Vibrio Infections | 11 | 2020 | 33 | 2.480 |
Why?
|
| Escherichia coli | 36 | 2024 | 4214 | 2.480 |
Why?
|
| Gene Transfer, Horizontal | 12 | 2020 | 145 | 2.470 |
Why?
|
| Escherichia coli Proteins | 20 | 2019 | 1052 | 2.460 |
Why?
|
| Cell Wall | 11 | 2022 | 422 | 2.450 |
Why?
|
| Rabbits | 38 | 2021 | 4886 | 2.400 |
Why?
|
| Vibrio | 8 | 2019 | 39 | 2.320 |
Why?
|
| RNA, Bacterial | 10 | 2011 | 391 | 2.310 |
Why?
|
| Intestinal Mucosa | 17 | 2023 | 3038 | 2.180 |
Why?
|
| RNA, Transfer | 7 | 2023 | 313 | 2.170 |
Why?
|
| Enterobacteriaceae Infections | 5 | 2023 | 186 | 2.080 |
Why?
|
| Shiga Toxin | 6 | 2023 | 34 | 2.050 |
Why?
|
| Mutagenesis, Insertional | 13 | 2019 | 655 | 1.900 |
Why?
|
| Liver Abscess | 2 | 2024 | 82 | 1.830 |
Why?
|
| Sigma Factor | 7 | 2018 | 174 | 1.780 |
Why?
|
| Listeriosis | 4 | 2021 | 149 | 1.620 |
Why?
|
| Vaccines, Attenuated | 6 | 2021 | 341 | 1.620 |
Why?
|
| Peptidoglycan | 10 | 2022 | 246 | 1.590 |
Why?
|
| Bacterial Outer Membrane Proteins | 14 | 2018 | 404 | 1.580 |
Why?
|
| RNA, Untranslated | 8 | 2013 | 454 | 1.520 |
Why?
|
| Inovirus | 6 | 2006 | 12 | 1.510 |
Why?
|
| Chemotaxis | 6 | 2017 | 607 | 1.420 |
Why?
|
| Penicillin-Binding Proteins | 4 | 2018 | 137 | 1.410 |
Why?
|
| Genetic Fitness | 2 | 2022 | 121 | 1.360 |
Why?
|
| DNA Replication | 11 | 2015 | 1397 | 1.350 |
Why?
|
| Amino Acids | 7 | 2021 | 1727 | 1.350 |
Why?
|
| Listeria monocytogenes | 3 | 2021 | 250 | 1.340 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 5 | 2023 | 28 | 1.320 |
Why?
|
| Diarrhea | 10 | 2023 | 1343 | 1.260 |
Why?
|
| Disease Outbreaks | 10 | 2022 | 1768 | 1.160 |
Why?
|
| Adhesins, Bacterial | 7 | 2012 | 119 | 1.100 |
Why?
|
| Replication Origin | 9 | 2017 | 77 | 1.070 |
Why?
|
| Animals | 118 | 2024 | 168561 | 1.070 |
Why?
|
| Interspersed Repetitive Sequences | 4 | 2013 | 54 | 1.060 |
Why?
|
| Anti-Bacterial Agents | 20 | 2023 | 7153 | 1.050 |
Why?
|
| Serratia marcescens | 2 | 2023 | 45 | 1.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 8 | 2020 | 3585 | 1.030 |
Why?
|
| Gram-Negative Bacteria | 2 | 2022 | 270 | 1.030 |
Why?
|
| Fish Diseases | 3 | 2018 | 38 | 1.000 |
Why?
|
| Genomic Islands | 3 | 2015 | 51 | 0.990 |
Why?
|
| Drug Resistance, Bacterial | 11 | 2021 | 1032 | 0.990 |
Why?
|
| Sequence Analysis, DNA | 21 | 2019 | 4801 | 0.980 |
Why?
|
| Chromosome Segregation | 4 | 2012 | 236 | 0.940 |
Why?
|
| Recombination, Genetic | 11 | 2016 | 1586 | 0.940 |
Why?
|
| Vaccines, Inactivated | 2 | 2022 | 184 | 0.930 |
Why?
|
| Molecular Sequence Data | 41 | 2015 | 18112 | 0.910 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2023 | 436 | 0.900 |
Why?
|
| Vibrio cholerae O1 | 4 | 2022 | 242 | 0.890 |
Why?
|
| Anticodon | 1 | 2022 | 25 | 0.880 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2022 | 36 | 0.880 |
Why?
|
| Endogenous Retroviruses | 1 | 2024 | 112 | 0.870 |
Why?
|
| Animals, Suckling | 11 | 2020 | 72 | 0.870 |
Why?
|
| Pseudouridine | 1 | 2022 | 24 | 0.870 |
Why?
|
| Photobacterium | 2 | 2015 | 2 | 0.870 |
Why?
|
| Mice | 68 | 2024 | 81045 | 0.860 |
Why?
|
| Base Sequence | 35 | 2015 | 12797 | 0.860 |
Why?
|
| Animals, Newborn | 10 | 2015 | 2723 | 0.850 |
Why?
|
| Prophages | 3 | 2009 | 38 | 0.840 |
Why?
|
| Lysogeny | 9 | 2007 | 67 | 0.840 |
Why?
|
| Gram-Positive Bacteria | 1 | 2022 | 184 | 0.810 |
Why?
|
| Evolution, Molecular | 8 | 2013 | 1937 | 0.810 |
Why?
|
| Cell Polarity | 3 | 2013 | 644 | 0.810 |
Why?
|
| Mucin-2 | 1 | 2021 | 49 | 0.790 |
Why?
|
| Bacterial Adhesion | 8 | 2021 | 316 | 0.760 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2022 | 156 | 0.750 |
Why?
|
| Endopeptidases | 2 | 2015 | 772 | 0.750 |
Why?
|
| Bacterial Toxins | 5 | 2010 | 933 | 0.730 |
Why?
|
| Streptococcus | 2 | 2023 | 197 | 0.710 |
Why?
|
| Proteobacteria | 1 | 2019 | 45 | 0.700 |
Why?
|
| Disease Models, Animal | 21 | 2021 | 18006 | 0.700 |
Why?
|
| Genomics | 10 | 2022 | 5692 | 0.700 |
Why?
|
| Quorum Sensing | 3 | 2018 | 131 | 0.700 |
Why?
|
| Shigella | 1 | 2020 | 73 | 0.690 |
Why?
|
| Fimbriae Proteins | 6 | 2015 | 134 | 0.690 |
Why?
|
| Polyribonucleotide Nucleotidyltransferase | 1 | 2019 | 5 | 0.690 |
Why?
|
| Serotonin | 1 | 2024 | 1024 | 0.680 |
Why?
|
| Salmonella Infections | 1 | 2020 | 173 | 0.680 |
Why?
|
| Streptococcal Infections | 2 | 2023 | 637 | 0.680 |
Why?
|
| Regulon | 5 | 2015 | 69 | 0.680 |
Why?
|
| Viral Proteins | 10 | 2009 | 1899 | 0.670 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2023 | 1825 | 0.660 |
Why?
|
| Endoribonucleases | 2 | 2019 | 228 | 0.650 |
Why?
|
| Membrane Proteins | 13 | 2021 | 7873 | 0.650 |
Why?
|
| Carrier Proteins | 7 | 2022 | 5019 | 0.640 |
Why?
|
| Hemolytic-Uremic Syndrome | 4 | 2013 | 110 | 0.640 |
Why?
|
| beta-Lactams | 2 | 2019 | 159 | 0.640 |
Why?
|
| RNA Helicases | 1 | 2019 | 142 | 0.630 |
Why?
|
| Intestine, Small | 6 | 2014 | 1243 | 0.620 |
Why?
|
| Repressor Proteins | 12 | 2018 | 3020 | 0.620 |
Why?
|
| DNA-Binding Proteins | 15 | 2017 | 9639 | 0.610 |
Why?
|
| Proteomics | 3 | 2021 | 3618 | 0.610 |
Why?
|
| Host Factor 1 Protein | 2 | 2009 | 15 | 0.600 |
Why?
|
| DNA Helicases | 2 | 2015 | 861 | 0.590 |
Why?
|
| Peptide Hydrolases | 2 | 2020 | 627 | 0.590 |
Why?
|
| Microvilli | 2 | 2014 | 241 | 0.580 |
Why?
|
| Interferon Type I | 1 | 2020 | 542 | 0.570 |
Why?
|
| D-Amino-Acid Oxidase | 1 | 2016 | 27 | 0.570 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 4 | 2009 | 563 | 0.570 |
Why?
|
| Trans-Activators | 6 | 2018 | 2924 | 0.570 |
Why?
|
| Bacteremia | 2 | 2021 | 962 | 0.560 |
Why?
|
| Shiga Toxin 1 | 4 | 2006 | 42 | 0.550 |
Why?
|
| Bacterial Load | 4 | 2021 | 153 | 0.550 |
Why?
|
| Gene Deletion | 14 | 2016 | 2751 | 0.550 |
Why?
|
| Coliphages | 5 | 2007 | 120 | 0.540 |
Why?
|
| Models, Genetic | 11 | 2020 | 3493 | 0.540 |
Why?
|
| Microbial Viability | 6 | 2022 | 234 | 0.540 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2015 | 23 | 0.530 |
Why?
|
| Lysosomes | 1 | 2020 | 893 | 0.530 |
Why?
|
| Probiotics | 1 | 2019 | 351 | 0.530 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2015 | 232 | 0.520 |
Why?
|
| Bacterial Infections | 1 | 2024 | 1389 | 0.520 |
Why?
|
| Serine Endopeptidases | 4 | 2016 | 1073 | 0.520 |
Why?
|
| Multienzyme Complexes | 1 | 2019 | 686 | 0.520 |
Why?
|
| Siderophores | 1 | 2015 | 56 | 0.510 |
Why?
|
| Citrobacter rodentium | 3 | 2023 | 65 | 0.510 |
Why?
|
| Lectins | 2 | 2022 | 514 | 0.500 |
Why?
|
| beta-Lactam Resistance | 1 | 2015 | 79 | 0.500 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2017 | 413 | 0.500 |
Why?
|
| Caulobacter crescentus | 2 | 2015 | 24 | 0.500 |
Why?
|
| Genetic Variation | 7 | 2015 | 6540 | 0.500 |
Why?
|
| Carboxypeptidases | 1 | 2015 | 176 | 0.500 |
Why?
|
| Enteritis | 2 | 2014 | 160 | 0.500 |
Why?
|
| Expressed Sequence Tags | 1 | 2015 | 255 | 0.490 |
Why?
|
| Shiga Toxin 2 | 6 | 2009 | 21 | 0.490 |
Why?
|
| Genes, Viral | 7 | 2003 | 718 | 0.480 |
Why?
|
| Phylogeny | 10 | 2022 | 2797 | 0.480 |
Why?
|
| Peptidoglycan Glycosyltransferase | 1 | 2014 | 65 | 0.480 |
Why?
|
| Myxococcus xanthus | 1 | 2013 | 12 | 0.470 |
Why?
|
| Colon | 3 | 2021 | 1773 | 0.470 |
Why?
|
| Blood-Brain Barrier | 2 | 2023 | 1015 | 0.470 |
Why?
|
| Gastrointestinal Tract | 6 | 2020 | 814 | 0.470 |
Why?
|
| Drug Resistance, Microbial | 8 | 2023 | 860 | 0.470 |
Why?
|
| Vibrionaceae | 2 | 2010 | 2 | 0.470 |
Why?
|
| Recombinases | 5 | 2010 | 67 | 0.460 |
Why?
|
| Promoter Regions, Genetic | 12 | 2018 | 5867 | 0.460 |
Why?
|
| Amidohydrolases | 1 | 2014 | 169 | 0.460 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 1152 | 0.460 |
Why?
|
| Cell Membrane | 2 | 2022 | 3744 | 0.460 |
Why?
|
| Protein Binding | 16 | 2018 | 9387 | 0.450 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2023 | 1210 | 0.450 |
Why?
|
| Amino Acid Sequence | 18 | 2014 | 13814 | 0.450 |
Why?
|
| Epithelial Cells | 6 | 2021 | 3678 | 0.450 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2005 | 442 | 0.450 |
Why?
|
| Population Dynamics | 1 | 2015 | 301 | 0.450 |
Why?
|
| Protein Kinases | 4 | 2015 | 1638 | 0.440 |
Why?
|
| Immunity, Mucosal | 1 | 2016 | 491 | 0.440 |
Why?
|
| Pasteurella Infections | 2 | 2008 | 8 | 0.430 |
Why?
|
| Feces | 6 | 2020 | 1394 | 0.430 |
Why?
|
| 5' Untranslated Regions | 2 | 2013 | 249 | 0.430 |
Why?
|
| Dysentery | 1 | 2012 | 12 | 0.430 |
Why?
|
| DNA Nucleotidyltransferases | 2 | 2003 | 193 | 0.430 |
Why?
|
| Suppression, Genetic | 2 | 2009 | 196 | 0.420 |
Why?
|
| Transcription Factors | 13 | 2016 | 12164 | 0.420 |
Why?
|
| Gene Regulatory Networks | 4 | 2020 | 1707 | 0.420 |
Why?
|
| Blood Proteins | 3 | 2006 | 1122 | 0.420 |
Why?
|
| Pyocins | 1 | 2011 | 5 | 0.420 |
Why?
|
| Streptococcus equi | 2 | 2023 | 9 | 0.410 |
Why?
|
| Software | 4 | 2014 | 4434 | 0.410 |
Why?
|
| Transduction, Genetic | 9 | 2006 | 913 | 0.400 |
Why?
|
| Antimicrobial Cationic Peptides | 4 | 2023 | 362 | 0.400 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2013 | 261 | 0.400 |
Why?
|
| Cytidine | 2 | 2022 | 68 | 0.390 |
Why?
|
| Chromosome Mapping | 7 | 2017 | 4742 | 0.390 |
Why?
|
| Haiti | 4 | 2022 | 551 | 0.390 |
Why?
|
| Gene Library | 4 | 2016 | 1076 | 0.390 |
Why?
|
| Integrases | 3 | 2004 | 533 | 0.390 |
Why?
|
| Antibodies, Bacterial | 5 | 2020 | 1469 | 0.380 |
Why?
|
| Streptomycin | 3 | 2020 | 69 | 0.380 |
Why?
|
| Genome, Viral | 5 | 2012 | 667 | 0.380 |
Why?
|
| Adenosine Triphosphatases | 3 | 2011 | 836 | 0.380 |
Why?
|
| Amino Acyl-tRNA Synthetases | 2 | 2023 | 91 | 0.380 |
Why?
|
| Penaeidae | 1 | 2010 | 22 | 0.380 |
Why?
|
| Flagellin | 2 | 2018 | 125 | 0.380 |
Why?
|
| DNA, Superhelical | 1 | 2010 | 50 | 0.380 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2010 | 87 | 0.370 |
Why?
|
| Genetic Complementation Test | 5 | 2015 | 561 | 0.370 |
Why?
|
| Operator Regions, Genetic | 3 | 2004 | 33 | 0.370 |
Why?
|
| Luciferases | 1 | 2012 | 733 | 0.370 |
Why?
|
| Gene Flow | 1 | 2010 | 79 | 0.370 |
Why?
|
| Adaptive Immunity | 3 | 2020 | 712 | 0.360 |
Why?
|
| Salmonella typhimurium | 3 | 2020 | 351 | 0.360 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2009 | 32 | 0.360 |
Why?
|
| Iron | 6 | 2022 | 1773 | 0.360 |
Why?
|
| Mutation | 21 | 2019 | 29717 | 0.360 |
Why?
|
| Antitoxins | 2 | 2014 | 82 | 0.360 |
Why?
|
| Binding Sites | 9 | 2017 | 6115 | 0.360 |
Why?
|
| Integration Host Factors | 2 | 2006 | 13 | 0.350 |
Why?
|
| Virus Activation | 5 | 2005 | 319 | 0.350 |
Why?
|
| Sepsis | 1 | 2024 | 2589 | 0.350 |
Why?
|
| Genetic Vectors | 1 | 2019 | 3420 | 0.350 |
Why?
|
| Computational Biology | 9 | 2021 | 3518 | 0.350 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 1213 | 0.350 |
Why?
|
| Microbial Sensitivity Tests | 7 | 2023 | 1871 | 0.350 |
Why?
|
| Immunity, Innate | 4 | 2023 | 2956 | 0.350 |
Why?
|
| Porins | 1 | 2009 | 81 | 0.340 |
Why?
|
| Sequence Analysis, RNA | 3 | 2014 | 2011 | 0.340 |
Why?
|
| Signal Transduction | 10 | 2021 | 23387 | 0.330 |
Why?
|
| Edwardsiella | 2 | 2018 | 6 | 0.330 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 1989 | 0.320 |
Why?
|
| Virus Integration | 5 | 2012 | 297 | 0.320 |
Why?
|
| O Antigens | 4 | 2023 | 193 | 0.320 |
Why?
|
| Gene Expression Profiling | 11 | 2021 | 9410 | 0.320 |
Why?
|
| Multigene Family | 4 | 2021 | 1102 | 0.320 |
Why?
|
| DNA Replication Timing | 2 | 2005 | 35 | 0.310 |
Why?
|
| Amino Acid Isomerases | 3 | 2013 | 34 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 8 | 2023 | 21821 | 0.310 |
Why?
|
| Proviruses | 5 | 2002 | 316 | 0.310 |
Why?
|
| Epigenomics | 1 | 2013 | 902 | 0.300 |
Why?
|
| Conserved Sequence | 5 | 2010 | 1202 | 0.300 |
Why?
|
| Bacteriophage P1 | 1 | 2006 | 10 | 0.300 |
Why?
|
| UTP-Glucose-1-Phosphate Uridylyltransferase | 1 | 2006 | 6 | 0.300 |
Why?
|
| UDPglucose 4-Epimerase | 1 | 2006 | 16 | 0.300 |
Why?
|
| Cell Division | 2 | 2014 | 4564 | 0.300 |
Why?
|
| Protein Transport | 6 | 2021 | 1988 | 0.290 |
Why?
|
| Norepinephrine | 3 | 2016 | 909 | 0.290 |
Why?
|
| Humans | 83 | 2023 | 742088 | 0.290 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 4455 | 0.280 |
Why?
|
| Biofilms | 4 | 2023 | 613 | 0.280 |
Why?
|
| Sequence Alignment | 6 | 2011 | 2257 | 0.280 |
Why?
|
| Centromere | 1 | 2007 | 220 | 0.280 |
Why?
|
| Integrons | 1 | 2006 | 20 | 0.280 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2007 | 177 | 0.280 |
Why?
|
| Bacillus subtilis | 1 | 2009 | 359 | 0.280 |
Why?
|
| Heat-Shock Proteins | 2 | 2009 | 822 | 0.280 |
Why?
|
| DNA, Complementary | 1 | 2009 | 2049 | 0.280 |
Why?
|
| Mitomycin | 5 | 2005 | 259 | 0.270 |
Why?
|
| Anti-Infective Agents | 3 | 2009 | 971 | 0.270 |
Why?
|
| Transcription, Genetic | 12 | 2018 | 7721 | 0.270 |
Why?
|
| Deinococcus | 2 | 2016 | 6 | 0.270 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 12071 | 0.260 |
Why?
|
| Rec A Recombinases | 3 | 2016 | 51 | 0.260 |
Why?
|
| Down-Regulation | 5 | 2015 | 3001 | 0.260 |
Why?
|
| Flagella | 2 | 2018 | 101 | 0.260 |
Why?
|
| Bacteriophage lambda | 2 | 2002 | 148 | 0.260 |
Why?
|
| Ecosystem | 2 | 2021 | 471 | 0.260 |
Why?
|
| Butyrates | 1 | 2006 | 163 | 0.260 |
Why?
|
| Genetic Loci | 4 | 2018 | 2572 | 0.260 |
Why?
|
| RNA Stability | 1 | 2007 | 322 | 0.260 |
Why?
|
| Naphthalenes | 1 | 2006 | 194 | 0.260 |
Why?
|
| Gastroenteritis | 1 | 2007 | 245 | 0.250 |
Why?
|
| Virus Replication | 6 | 2003 | 2531 | 0.250 |
Why?
|
| Penicillins | 2 | 2018 | 378 | 0.250 |
Why?
|
| Mice, Knockout | 5 | 2024 | 14554 | 0.240 |
Why?
|
| Chloramphenicol Resistance | 1 | 2003 | 6 | 0.240 |
Why?
|
| Staphylococcus Phages | 1 | 2003 | 7 | 0.240 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2006 | 371 | 0.240 |
Why?
|
| Fucose | 2 | 2016 | 125 | 0.240 |
Why?
|
| Substrate Specificity | 5 | 2013 | 1802 | 0.240 |
Why?
|
| Open Reading Frames | 5 | 2010 | 810 | 0.240 |
Why?
|
| Bacterial Secretion Systems | 2 | 2014 | 38 | 0.240 |
Why?
|
| Operon | 4 | 2011 | 360 | 0.240 |
Why?
|
| Enterobacter cloacae | 1 | 2023 | 20 | 0.230 |
Why?
|
| Metalloendopeptidases | 3 | 2003 | 396 | 0.230 |
Why?
|
| Gene Targeting | 2 | 2018 | 880 | 0.230 |
Why?
|
| Biological Evolution | 4 | 2015 | 1074 | 0.230 |
Why?
|
| Enterocytes | 2 | 2023 | 225 | 0.230 |
Why?
|
| Bacterial Capsules | 3 | 2008 | 251 | 0.230 |
Why?
|
| Bacteriophage M13 | 1 | 2003 | 40 | 0.220 |
Why?
|
| Genetic Testing | 1 | 2016 | 3439 | 0.220 |
Why?
|
| Enzyme Inhibitors | 2 | 2012 | 3800 | 0.220 |
Why?
|
| Satellite Viruses | 1 | 2002 | 10 | 0.220 |
Why?
|
| Cattle Diseases | 1 | 2003 | 53 | 0.220 |
Why?
|
| Attachment Sites, Microbiological | 4 | 2004 | 26 | 0.220 |
Why?
|
| Helper Viruses | 1 | 2002 | 58 | 0.220 |
Why?
|
| Adenosine Triphosphate | 2 | 2010 | 2024 | 0.220 |
Why?
|
| Kinetics | 4 | 2019 | 6474 | 0.220 |
Why?
|
| Viral Fusion Proteins | 1 | 2003 | 95 | 0.220 |
Why?
|
| Peptide Termination Factors | 2 | 2001 | 55 | 0.220 |
Why?
|
| Administration, Oral | 3 | 2021 | 3913 | 0.210 |
Why?
|
| Fimbriae, Bacterial | 4 | 2012 | 138 | 0.210 |
Why?
|
| Vibrio vulnificus | 2 | 2018 | 12 | 0.210 |
Why?
|
| Chloride Channels | 1 | 2003 | 225 | 0.210 |
Why?
|
| Enterotoxins | 1 | 2003 | 368 | 0.210 |
Why?
|
| Homeostasis | 3 | 2019 | 3335 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3236 | 0.200 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2020 | 2552 | 0.200 |
Why?
|
| Caco-2 Cells | 6 | 2021 | 387 | 0.200 |
Why?
|
| Cell Membrane Permeability | 2 | 2019 | 590 | 0.200 |
Why?
|
| DNA | 5 | 2017 | 7289 | 0.200 |
Why?
|
| Cell Cycle | 2 | 2011 | 2964 | 0.200 |
Why?
|
| DNA, Circular | 1 | 2001 | 96 | 0.200 |
Why?
|
| Detergents | 1 | 2021 | 230 | 0.190 |
Why?
|
| Germ-Free Life | 2 | 2021 | 188 | 0.190 |
Why?
|
| Nucleotides | 1 | 2024 | 463 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 4 | 2019 | 6382 | 0.190 |
Why?
|
| RNA, Transfer, Tyr | 1 | 2020 | 4 | 0.190 |
Why?
|
| Bacterial Typing Techniques | 2 | 2011 | 256 | 0.190 |
Why?
|
| Nitrates | 2 | 2020 | 265 | 0.190 |
Why?
|
| Cytidine Deaminase | 1 | 2022 | 251 | 0.190 |
Why?
|
| Markov Chains | 2 | 2014 | 969 | 0.190 |
Why?
|
| HT29 Cells | 1 | 2020 | 200 | 0.190 |
Why?
|
| Cephalosporins | 1 | 2021 | 203 | 0.190 |
Why?
|
| Antibodies, Monoclonal | 12 | 2020 | 9274 | 0.190 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2020 | 107 | 0.180 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2024 | 615 | 0.180 |
Why?
|
| Transcription Initiation Site | 3 | 2006 | 196 | 0.180 |
Why?
|
| Periplasmic Proteins | 1 | 2000 | 25 | 0.180 |
Why?
|
| Cell Nucleolus | 1 | 2020 | 166 | 0.180 |
Why?
|
| Inoviridae | 1 | 1999 | 3 | 0.180 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 561 | 0.180 |
Why?
|
| Models, Molecular | 5 | 2019 | 5454 | 0.180 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2023 | 238 | 0.180 |
Why?
|
| Protein Structure, Tertiary | 5 | 2012 | 3847 | 0.180 |
Why?
|
| HeLa Cells | 4 | 2013 | 3127 | 0.170 |
Why?
|
| Stereoisomerism | 2 | 2011 | 625 | 0.170 |
Why?
|
| Necrosis | 1 | 2024 | 1643 | 0.170 |
Why?
|
| Thiouridine | 1 | 2019 | 4 | 0.170 |
Why?
|
| Peptide Elongation Factor Tu | 1 | 2019 | 19 | 0.170 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2019 | 82 | 0.170 |
Why?
|
| Biomedical Research | 1 | 2015 | 3306 | 0.170 |
Why?
|
| Acetyltransferases | 1 | 2020 | 234 | 0.170 |
Why?
|
| Organ Specificity | 2 | 2021 | 2003 | 0.170 |
Why?
|
| RNA Editing | 1 | 2020 | 148 | 0.170 |
Why?
|
| DNA, Viral | 6 | 2001 | 2224 | 0.170 |
Why?
|
| Horses | 1 | 2019 | 304 | 0.160 |
Why?
|
| Receptors, Adrenergic | 2 | 2016 | 155 | 0.160 |
Why?
|
| Archaea | 1 | 2019 | 59 | 0.160 |
Why?
|
| Trihexosylceramides | 1 | 2018 | 32 | 0.160 |
Why?
|
| Gonorrhea | 1 | 2023 | 335 | 0.160 |
Why?
|
| Francisella tularensis | 2 | 2009 | 56 | 0.160 |
Why?
|
| Vibrio alginolyticus | 1 | 2018 | 3 | 0.160 |
Why?
|
| Serotyping | 3 | 2010 | 338 | 0.160 |
Why?
|
| Staphylococcus aureus | 2 | 2023 | 1449 | 0.160 |
Why?
|
| Hemagglutinins | 1 | 1998 | 117 | 0.160 |
Why?
|
| Sequence Deletion | 3 | 2018 | 1526 | 0.160 |
Why?
|
| Membrane Transport Proteins | 4 | 2014 | 1028 | 0.160 |
Why?
|
| Phosphorylation | 5 | 2018 | 8436 | 0.150 |
Why?
|
| Molecular Epidemiology | 3 | 2013 | 468 | 0.150 |
Why?
|
| Macrophages | 2 | 2023 | 5655 | 0.150 |
Why?
|
| GTP Phosphohydrolases | 1 | 2021 | 508 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2011 | 2837 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 3 | 2013 | 2699 | 0.150 |
Why?
|
| Biosynthetic Pathways | 1 | 2018 | 137 | 0.150 |
Why?
|
| DNA Methylation | 4 | 2015 | 4282 | 0.150 |
Why?
|
| Metagenome | 1 | 2020 | 417 | 0.150 |
Why?
|
| Microbial Interactions | 1 | 2017 | 76 | 0.150 |
Why?
|
| Acetylation | 1 | 2020 | 1085 | 0.150 |
Why?
|
| Metagenomics | 1 | 2020 | 430 | 0.150 |
Why?
|
| Protein Multimerization | 3 | 2017 | 971 | 0.150 |
Why?
|
| Sphingolipids | 1 | 2018 | 159 | 0.150 |
Why?
|
| Cell Survival | 2 | 2018 | 5872 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4751 | 0.150 |
Why?
|
| Hydrogen Peroxide | 2 | 2016 | 730 | 0.150 |
Why?
|
| Bacitracin | 1 | 2016 | 25 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 6 | 2011 | 6171 | 0.140 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 6 | 1988 | 834 | 0.140 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2016 | 103 | 0.140 |
Why?
|
| Lymphocytes | 2 | 2023 | 2614 | 0.140 |
Why?
|
| Central Nervous System | 1 | 2024 | 1354 | 0.140 |
Why?
|
| Th17 Cells | 1 | 2023 | 765 | 0.140 |
Why?
|
| Base Composition | 1 | 2016 | 293 | 0.140 |
Why?
|
| Drug Resistance | 1 | 2002 | 1608 | 0.140 |
Why?
|
| Blood | 1 | 2018 | 598 | 0.140 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2000 | 794 | 0.140 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 2 | 2007 | 18 | 0.140 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2017 | 136 | 0.140 |
Why?
|
| Ciprofloxacin | 3 | 2023 | 314 | 0.140 |
Why?
|
| Quality Control | 1 | 2019 | 841 | 0.140 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2015 | 1723 | 0.140 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 939 | 0.130 |
Why?
|
| Models, Theoretical | 2 | 2018 | 3584 | 0.130 |
Why?
|
| Gallbladder | 1 | 2017 | 301 | 0.130 |
Why?
|
| Sheep | 1 | 2018 | 1437 | 0.130 |
Why?
|
| Interleukin-8 | 2 | 2021 | 689 | 0.130 |
Why?
|
| Sulfates | 1 | 2016 | 390 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 987 | 0.130 |
Why?
|
| Female | 19 | 2023 | 379592 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 944 | 0.130 |
Why?
|
| Capsid Proteins | 2 | 2012 | 479 | 0.130 |
Why?
|
| Glycopeptides | 1 | 2016 | 224 | 0.130 |
Why?
|
| Deoxyribonuclease I | 2 | 2006 | 228 | 0.130 |
Why?
|
| DNA Primers | 6 | 2014 | 2892 | 0.130 |
Why?
|
| Cefsulodin | 1 | 2014 | 5 | 0.130 |
Why?
|
| Genetic Drift | 1 | 2014 | 43 | 0.130 |
Why?
|
| Peptides | 2 | 2023 | 4392 | 0.130 |
Why?
|
| Models, Animal | 1 | 2021 | 2170 | 0.130 |
Why?
|
| Cloning, Molecular | 4 | 2009 | 4322 | 0.120 |
Why?
|
| Immunization | 1 | 2019 | 1255 | 0.120 |
Why?
|
| Escherichia coli Vaccines | 1 | 2014 | 11 | 0.120 |
Why?
|
| Nalidixic Acid | 1 | 2014 | 19 | 0.120 |
Why?
|
| Biological Transport | 1 | 2019 | 2119 | 0.120 |
Why?
|
| Fishes | 1 | 2017 | 569 | 0.120 |
Why?
|
| Models, Biological | 4 | 2016 | 9581 | 0.120 |
Why?
|
| Receptors, Cholinergic | 2 | 1987 | 238 | 0.120 |
Why?
|
| Antigens, Bacterial | 2 | 2023 | 1170 | 0.120 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2013 | 56 | 0.120 |
Why?
|
| Agar | 1 | 2013 | 56 | 0.120 |
Why?
|
| DNA Topoisomerase IV | 1 | 2013 | 40 | 0.120 |
Why?
|
| Cecum | 2 | 2012 | 237 | 0.120 |
Why?
|
| DNA Damage | 3 | 2014 | 2423 | 0.120 |
Why?
|
| Cluster Analysis | 2 | 2019 | 2713 | 0.120 |
Why?
|
| Molecular Weight | 1 | 2016 | 2255 | 0.120 |
Why?
|
| RNA, Small Untranslated | 1 | 2014 | 76 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1780 | 0.120 |
Why?
|
| Colony Count, Microbial | 3 | 2010 | 331 | 0.120 |
Why?
|
| Chlorides | 2 | 2009 | 667 | 0.120 |
Why?
|
| Antibiosis | 1 | 2013 | 46 | 0.120 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2014 | 102 | 0.120 |
Why?
|
| Radiation Tolerance | 1 | 2016 | 484 | 0.120 |
Why?
|
| Cell Line | 4 | 2018 | 15994 | 0.120 |
Why?
|
| Peptide Fragments | 3 | 2012 | 5095 | 0.110 |
Why?
|
| Goblet Cells | 1 | 2016 | 287 | 0.110 |
Why?
|
| Histocompatibility Antigens Class II | 5 | 1987 | 1470 | 0.110 |
Why?
|
| Surface Properties | 1 | 2016 | 1182 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 808 | 0.110 |
Why?
|
| beta-Glucans | 1 | 2014 | 123 | 0.110 |
Why?
|
| Spleen | 4 | 2017 | 2359 | 0.110 |
Why?
|
| Renilla | 1 | 2012 | 6 | 0.110 |
Why?
|
| Nucleic Acid Conformation | 2 | 2010 | 914 | 0.110 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2014 | 194 | 0.110 |
Why?
|
| Origin Recognition Complex | 1 | 2012 | 19 | 0.110 |
Why?
|
| Colitis | 1 | 2021 | 1149 | 0.110 |
Why?
|
| Legionnaires' Disease | 1 | 1993 | 48 | 0.110 |
Why?
|
| Vancomycin | 1 | 2016 | 500 | 0.110 |
Why?
|
| Gene Dosage | 3 | 2004 | 1251 | 0.110 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 195 | 0.110 |
Why?
|
| Legionella pneumophila | 1 | 1993 | 46 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2009 | 2088 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 2203 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 2126 | 0.110 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2016 | 947 | 0.110 |
Why?
|
| Synthetic Biology | 1 | 2015 | 179 | 0.110 |
Why?
|
| Pasteurella multocida | 1 | 1992 | 4 | 0.110 |
Why?
|
| Nepal | 1 | 2013 | 294 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2009 | 3920 | 0.110 |
Why?
|
| Flow Cytometry | 4 | 2015 | 5975 | 0.110 |
Why?
|
| Brain | 2 | 2019 | 26343 | 0.110 |
Why?
|
| Culture Media | 2 | 2006 | 902 | 0.110 |
Why?
|
| Bacteroides | 1 | 2012 | 161 | 0.110 |
Why?
|
| Genes, Essential | 1 | 2013 | 182 | 0.100 |
Why?
|
| DNA Repair | 2 | 2016 | 2042 | 0.100 |
Why?
|
| Transfection | 2 | 2013 | 5892 | 0.100 |
Why?
|
| Alleles | 2 | 2019 | 6931 | 0.100 |
Why?
|
| Vibrio cholerae non-O1 | 1 | 2011 | 3 | 0.100 |
Why?
|
| Gammaproteobacteria | 1 | 2011 | 28 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2015 | 1683 | 0.100 |
Why?
|
| Peptidyl Transferases | 1 | 2011 | 54 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2009 | 5180 | 0.100 |
Why?
|
| Lipids | 1 | 2022 | 3302 | 0.100 |
Why?
|
| Peptide Synthases | 1 | 2011 | 80 | 0.100 |
Why?
|
| Cyclic AMP | 1 | 2015 | 1470 | 0.100 |
Why?
|
| New Caledonia | 1 | 2010 | 3 | 0.100 |
Why?
|
| Replicon | 1 | 2010 | 34 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2007 | 3731 | 0.100 |
Why?
|
| Systems Biology | 1 | 2015 | 469 | 0.100 |
Why?
|
| Cellulitis | 1 | 1993 | 206 | 0.100 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2011 | 300 | 0.100 |
Why?
|
| Swine | 2 | 2019 | 5934 | 0.100 |
Why?
|
| Adenosine Diphosphate | 2 | 2010 | 425 | 0.100 |
Why?
|
| Hydrolysis | 2 | 2010 | 682 | 0.090 |
Why?
|
| Colitis, Ulcerative | 1 | 2022 | 1901 | 0.090 |
Why?
|
| Aquatic Organisms | 1 | 2010 | 48 | 0.090 |
Why?
|
| History, 18th Century | 1 | 2010 | 214 | 0.090 |
Why?
|
| Spores, Bacterial | 1 | 2010 | 118 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 647 | 0.090 |
Why?
|
| DNA Gyrase | 1 | 2010 | 82 | 0.090 |
Why?
|
| Molecular Conformation | 1 | 2011 | 563 | 0.090 |
Why?
|
| Algorithms | 5 | 2020 | 13853 | 0.090 |
Why?
|
| RNA, Messenger | 4 | 2009 | 13029 | 0.090 |
Why?
|
| Point Mutation | 1 | 2015 | 1624 | 0.090 |
Why?
|
| Spinacia oleracea | 1 | 2009 | 12 | 0.090 |
Why?
|
| Isoleucine | 1 | 2009 | 111 | 0.090 |
Why?
|
| Environment | 2 | 2014 | 1115 | 0.090 |
Why?
|
| Heat-Shock Response | 2 | 2009 | 165 | 0.090 |
Why?
|
| Mortality | 1 | 2021 | 2857 | 0.090 |
Why?
|
| Foodborne Diseases | 1 | 2009 | 39 | 0.090 |
Why?
|
| Gene Transfer Techniques | 3 | 2002 | 1224 | 0.090 |
Why?
|
| Anxiety | 1 | 2024 | 4279 | 0.090 |
Why?
|
| Fermentation | 2 | 2020 | 143 | 0.090 |
Why?
|
| beta-Lactamases | 2 | 2023 | 303 | 0.090 |
Why?
|
| Lipopolysaccharides | 3 | 1999 | 2211 | 0.090 |
Why?
|
| Lipoproteins | 1 | 2014 | 876 | 0.080 |
Why?
|
| Endocytosis | 1 | 2014 | 983 | 0.080 |
Why?
|
| Germany | 1 | 2011 | 860 | 0.080 |
Why?
|
| Genes, Regulator | 2 | 2004 | 378 | 0.080 |
Why?
|
| Restriction Mapping | 2 | 2000 | 878 | 0.080 |
Why?
|
| Oxygen | 1 | 2020 | 4169 | 0.080 |
Why?
|
| Species Specificity | 3 | 2018 | 2479 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2021 | 3461 | 0.080 |
Why?
|
| Viral Vaccines | 1 | 1994 | 636 | 0.080 |
Why?
|
| Movement | 1 | 2015 | 1470 | 0.080 |
Why?
|
| Isoantibodies | 4 | 1987 | 680 | 0.080 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2008 | 27 | 0.080 |
Why?
|
| Gene Expression | 5 | 2009 | 7790 | 0.080 |
Why?
|
| Carboxy-Lyases | 1 | 2008 | 90 | 0.080 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 627 | 0.080 |
Why?
|
| Neutrophils | 1 | 2001 | 3711 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2021 | 10472 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2021 | 2301 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2015 | 1402 | 0.080 |
Why?
|
| Virion | 2 | 2000 | 433 | 0.080 |
Why?
|
| Leucine | 1 | 2009 | 560 | 0.080 |
Why?
|
| Gene Order | 1 | 2008 | 176 | 0.080 |
Why?
|
| Biopsy | 1 | 2020 | 6756 | 0.080 |
Why?
|
| Valine | 1 | 2009 | 413 | 0.080 |
Why?
|
| Epidemics | 1 | 2013 | 521 | 0.080 |
Why?
|
| Temperature | 2 | 2021 | 2207 | 0.080 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1987 | 158 | 0.080 |
Why?
|
| Antitubercular Agents | 1 | 2015 | 1319 | 0.070 |
Why?
|
| Alanine | 1 | 2009 | 572 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2440 | 0.070 |
Why?
|
| Methionine | 1 | 2009 | 590 | 0.070 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 3 | 1987 | 906 | 0.070 |
Why?
|
| Myasthenia Gravis | 2 | 1987 | 201 | 0.070 |
Why?
|
| Bacteriolysis | 1 | 2006 | 51 | 0.070 |
Why?
|
| Lac Operon | 1 | 2006 | 238 | 0.070 |
Why?
|
| Houseflies | 1 | 2006 | 7 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 4187 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2015 | 4211 | 0.070 |
Why?
|
| Naphthalimides | 1 | 2006 | 21 | 0.070 |
Why?
|
| Fetal Diseases | 1 | 1992 | 903 | 0.070 |
Why?
|
| Genotype | 1 | 2021 | 12946 | 0.070 |
Why?
|
| Environmental Microbiology | 1 | 2006 | 46 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 11363 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1999 | 768 | 0.070 |
Why?
|
| Rifampin | 2 | 2006 | 315 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2006 | 1801 | 0.070 |
Why?
|
| Calibration | 1 | 2008 | 815 | 0.070 |
Why?
|
| Serine | 2 | 2021 | 828 | 0.070 |
Why?
|
| Autoimmune Diseases | 5 | 1989 | 2130 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2014 | 6191 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2009 | 1547 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 3133 | 0.070 |
Why?
|
| Genetic Engineering | 1 | 2011 | 952 | 0.070 |
Why?
|
| Genes, MHC Class II | 2 | 1984 | 458 | 0.070 |
Why?
|
| Deoxyribonucleases | 1 | 2006 | 214 | 0.070 |
Why?
|
| Mutagenesis | 1 | 2009 | 1263 | 0.060 |
Why?
|
| DNA, Intergenic | 1 | 2005 | 107 | 0.060 |
Why?
|
| DNA Footprinting | 1 | 2004 | 98 | 0.060 |
Why?
|
| Catalysis | 1 | 2006 | 760 | 0.060 |
Why?
|
| F Factor | 1 | 2004 | 12 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2009 | 1086 | 0.060 |
Why?
|
| Cephalexin | 1 | 2004 | 37 | 0.060 |
Why?
|
| Data Mining | 1 | 2009 | 537 | 0.060 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2004 | 313 | 0.060 |
Why?
|
| Apoptosis | 1 | 2021 | 9715 | 0.060 |
Why?
|
| Microscopy, Video | 1 | 2005 | 245 | 0.060 |
Why?
|
| Communicable Disease Control | 1 | 2011 | 854 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2013 | 2500 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2006 | 936 | 0.060 |
Why?
|
| Time Factors | 5 | 2013 | 40054 | 0.060 |
Why?
|
| International Cooperation | 1 | 2010 | 1421 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2009 | 1176 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2007 | 559 | 0.060 |
Why?
|
| Mexico | 1 | 2006 | 688 | 0.060 |
Why?
|
| Inflammation | 1 | 2003 | 10578 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2009 | 1167 | 0.060 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4200 | 0.060 |
Why?
|
| Luminescent Proteins | 1 | 2006 | 853 | 0.060 |
Why?
|
| Superantigens | 1 | 2003 | 129 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2005 | 1581 | 0.060 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2003 | 159 | 0.060 |
Why?
|
| Shiga Toxins | 2 | 2000 | 41 | 0.060 |
Why?
|
| Systems Integration | 1 | 2005 | 440 | 0.060 |
Why?
|
| Polymorphism, Genetic | 3 | 2009 | 4328 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 12220 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2019 | 19223 | 0.060 |
Why?
|
| Ceftriaxone | 1 | 2023 | 168 | 0.060 |
Why?
|
| Blotting, Southern | 2 | 2000 | 803 | 0.050 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2023 | 98 | 0.050 |
Why?
|
| R Factors | 1 | 2002 | 44 | 0.050 |
Why?
|
| Acids | 1 | 2003 | 127 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2009 | 1051 | 0.050 |
Why?
|
| Terminator Regions, Genetic | 1 | 2002 | 28 | 0.050 |
Why?
|
| Isotope Labeling | 1 | 2004 | 414 | 0.050 |
Why?
|
| Phenotype | 4 | 2021 | 16331 | 0.050 |
Why?
|
| Hydrolases | 1 | 2023 | 139 | 0.050 |
Why?
|
| Micelles | 1 | 2023 | 203 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 3639 | 0.050 |
Why?
|
| Dimerization | 1 | 2003 | 893 | 0.050 |
Why?
|
| Sequence Analysis | 1 | 2002 | 256 | 0.050 |
Why?
|
| Siphoviridae | 1 | 2001 | 7 | 0.050 |
Why?
|
| Retroelements | 1 | 2002 | 164 | 0.050 |
Why?
|
| Providencia | 1 | 2001 | 2 | 0.050 |
Why?
|
| Disease Progression | 1 | 2018 | 13256 | 0.050 |
Why?
|
| Liver | 1 | 2017 | 7470 | 0.050 |
Why?
|
| Mitosis | 1 | 2006 | 1208 | 0.050 |
Why?
|
| Agglutination | 1 | 2020 | 43 | 0.050 |
Why?
|
| Skin | 1 | 2015 | 4353 | 0.050 |
Why?
|
| Cytokines | 2 | 2021 | 7317 | 0.050 |
Why?
|
| Mucus | 1 | 2022 | 321 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2016 | 5100 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1889 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2005 | 692 | 0.050 |
Why?
|
| Masks | 1 | 2023 | 195 | 0.050 |
Why?
|
| Solubility | 1 | 2002 | 1083 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2013 | 4013 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2005 | 1099 | 0.050 |
Why?
|
| Diphtheria Toxin | 1 | 2021 | 255 | 0.050 |
Why?
|
| Drug Design | 1 | 2006 | 1078 | 0.050 |
Why?
|
| Cryptosporidium parvum | 1 | 2000 | 43 | 0.050 |
Why?
|
| Viral Core Proteins | 1 | 2000 | 162 | 0.050 |
Why?
|
| Genes, Protozoan | 1 | 2000 | 163 | 0.050 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2020 | 150 | 0.050 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1992 | 2026 | 0.050 |
Why?
|
| Electron Transport | 1 | 2020 | 211 | 0.040 |
Why?
|
| Actins | 1 | 2007 | 2120 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8328 | 0.040 |
Why?
|
| India | 2 | 1998 | 2187 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2004 | 695 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2005 | 1059 | 0.040 |
Why?
|
| RNA, Ribosomal | 1 | 2020 | 246 | 0.040 |
Why?
|
| Genetic Linkage | 2 | 2014 | 2422 | 0.040 |
Why?
|
| Ileum | 2 | 2012 | 565 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1985 | 986 | 0.040 |
Why?
|
| Nitrite Reductases | 1 | 2018 | 5 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1999 | 212 | 0.040 |
Why?
|
| Flatfishes | 1 | 2018 | 2 | 0.040 |
Why?
|
| Ampicillin Resistance | 1 | 1998 | 11 | 0.040 |
Why?
|
| Blood Bactericidal Activity | 2 | 1998 | 126 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2008 | 1932 | 0.040 |
Why?
|
| Aquaculture | 1 | 2018 | 25 | 0.040 |
Why?
|
| Anaerobiosis | 1 | 2018 | 140 | 0.040 |
Why?
|
| Gene Rearrangement | 1 | 2004 | 1179 | 0.040 |
Why?
|
| Lipid A | 1 | 2018 | 67 | 0.040 |
Why?
|
| Bangladesh | 1 | 2020 | 687 | 0.040 |
Why?
|
| T-Lymphocytes | 5 | 1988 | 10163 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2023 | 1141 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2001 | 527 | 0.040 |
Why?
|
| Nitrites | 1 | 2018 | 160 | 0.040 |
Why?
|
| Crystallography, X-Ray | 2 | 2013 | 2014 | 0.040 |
Why?
|
| Genetic Markers | 2 | 2006 | 2633 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 573 | 0.040 |
Why?
|
| Plant Roots | 1 | 2017 | 109 | 0.040 |
Why?
|
| Soil Microbiology | 1 | 2017 | 87 | 0.040 |
Why?
|
| Zea mays | 1 | 2017 | 105 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 992 | 0.040 |
Why?
|
| Ecology | 1 | 1997 | 105 | 0.040 |
Why?
|
| Cattle | 1 | 2003 | 3923 | 0.040 |
Why?
|
| Drug Tolerance | 1 | 2018 | 375 | 0.040 |
Why?
|
| Trace Elements | 1 | 2018 | 198 | 0.040 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2016 | 75 | 0.040 |
Why?
|
| Indoles | 1 | 2005 | 1834 | 0.030 |
Why?
|
| Chromohalobacter | 1 | 2015 | 1 | 0.030 |
Why?
|
| Geobacter | 1 | 2015 | 5 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10943 | 0.030 |
Why?
|
| Campylobacter jejuni | 1 | 2015 | 26 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 1040 | 0.030 |
Why?
|
| Digestive System | 1 | 1996 | 251 | 0.030 |
Why?
|
| Drug Resistance, Multiple | 1 | 1996 | 252 | 0.030 |
Why?
|
| Mammals | 1 | 2021 | 1135 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 1692 | 0.030 |
Why?
|
| Electrophoresis | 1 | 1994 | 240 | 0.030 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2020 | 569 | 0.030 |
Why?
|
| DNA Modification Methylases | 1 | 2015 | 206 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 1987 | 4664 | 0.030 |
Why?
|
| Alanine Racemase | 1 | 2013 | 5 | 0.030 |
Why?
|
| Protozoan Proteins | 1 | 2000 | 827 | 0.030 |
Why?
|
| Opsonin Proteins | 1 | 2014 | 150 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 2018 | 592 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 2867 | 0.030 |
Why?
|
| Genetic Code | 1 | 1994 | 154 | 0.030 |
Why?
|
| Zinc | 1 | 2018 | 683 | 0.030 |
Why?
|
| Endotoxins | 1 | 1996 | 525 | 0.030 |
Why?
|
| Male | 8 | 2021 | 349538 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2002 | 2899 | 0.030 |
Why?
|
| alpha-L-Fucosidase | 1 | 2012 | 8 | 0.030 |
Why?
|
| DNA Restriction-Modification Enzymes | 1 | 2012 | 11 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 2187 | 0.030 |
Why?
|
| Mice, Inbred Strains | 3 | 1999 | 1827 | 0.030 |
Why?
|
| Contig Mapping | 1 | 2012 | 54 | 0.030 |
Why?
|
| Epinephrine | 1 | 2016 | 793 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2016 | 643 | 0.030 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2014 | 236 | 0.030 |
Why?
|
| Genes, rRNA | 1 | 2012 | 70 | 0.030 |
Why?
|
| Spiro Compounds | 1 | 2012 | 76 | 0.030 |
Why?
|
| Morphogenesis | 1 | 1996 | 752 | 0.030 |
Why?
|
| Vaccines, Conjugate | 1 | 2014 | 331 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2000 | 2260 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2012 | 153 | 0.030 |
Why?
|
| Helicobacter pylori | 1 | 2015 | 381 | 0.030 |
Why?
|
| Cell Surface Extensions | 1 | 2012 | 67 | 0.030 |
Why?
|
| Decidua | 1 | 1992 | 86 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2010 | 2645 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 589 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 1899 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 1994 | 633 | 0.020 |
Why?
|
| Biotechnology | 1 | 2012 | 278 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3455 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 9735 | 0.020 |
Why?
|
| Antibody Formation | 2 | 1987 | 1402 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 19862 | 0.020 |
Why?
|
| Metabolomics | 1 | 2018 | 1467 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 3617 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 8925 | 0.020 |
Why?
|
| RNA, Ribosomal, 5S | 1 | 2009 | 11 | 0.020 |
Why?
|
| Mucins | 1 | 2012 | 564 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 1988 | 2524 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2009 | 377 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 6608 | 0.020 |
Why?
|
| Tularemia | 1 | 2008 | 35 | 0.020 |
Why?
|
| Salmonella Infections, Animal | 1 | 2008 | 65 | 0.020 |
Why?
|
| Intestine, Large | 1 | 2008 | 71 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2012 | 1062 | 0.020 |
Why?
|
| Kanamycin | 1 | 2007 | 64 | 0.020 |
Why?
|
| Toxoplasmosis, Animal | 1 | 1987 | 17 | 0.020 |
Why?
|
| Glycosyltransferases | 1 | 2008 | 113 | 0.020 |
Why?
|
| Adenine | 1 | 2012 | 936 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 1245 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 1992 | 542 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 713 | 0.020 |
Why?
|
| Europe | 1 | 2013 | 3339 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 1987 | 1161 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2023 | 11470 | 0.020 |
Why?
|
| Carbon | 1 | 2009 | 686 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2011 | 62966 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 1987 | 1663 | 0.020 |
Why?
|
| Immunoglobulin D | 1 | 1984 | 56 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 1970 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 16665 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 1987 | 389 | 0.010 |
Why?
|
| United States | 1 | 2010 | 69693 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 1987 | 518 | 0.010 |
Why?
|
| Small Molecule Libraries | 1 | 2008 | 721 | 0.010 |
Why?
|
| Placenta | 1 | 1992 | 1694 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 1987 | 2986 | 0.010 |
Why?
|
| Epitopes | 2 | 1988 | 2569 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1985 | 1583 | 0.010 |
Why?
|
| Fosfomycin | 1 | 2000 | 25 | 0.010 |
Why?
|
| Cryptosporidiosis | 1 | 2000 | 59 | 0.010 |
Why?
|
| Transposases | 1 | 1999 | 104 | 0.010 |
Why?
|
| Freeze Substitution | 1 | 1998 | 2 | 0.010 |
Why?
|
| Xylenes | 1 | 1998 | 8 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1984 | 1538 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 2455 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2008 | 2452 | 0.010 |
Why?
|
| Sunlight | 1 | 2000 | 325 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2000 | 758 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 2906 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 213127 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 3769 | 0.010 |
Why?
|
| Lymph Nodes | 2 | 1987 | 3465 | 0.010 |
Why?
|
| Quality of Life | 1 | 2018 | 12730 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1983 | 1606 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1989 | 4379 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1999 | 1866 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1983 | 3862 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1987 | 5519 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1987 | 4554 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2000 | 3139 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 20928 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1998 | 1538 | 0.010 |
Why?
|
| Rats | 1 | 1987 | 24265 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 3770 | 0.010 |
Why?
|
| Pregnancy | 1 | 1992 | 29087 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1983 | 4414 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1988 | 841 | 0.000 |
Why?
|
| Antigens, Protozoan | 1 | 1987 | 322 | 0.000 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1985 | 201 | 0.000 |
Why?
|
| Clone Cells | 1 | 1988 | 1692 | 0.000 |
Why?
|
| Histocompatibility Antigens | 1 | 1986 | 471 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1988 | 804 | 0.000 |
Why?
|
| Genes | 1 | 1988 | 1892 | 0.000 |
Why?
|
| Random Allocation | 1 | 1988 | 2425 | 0.000 |
Why?
|
| Lymphatic System | 1 | 1985 | 253 | 0.000 |
Why?
|
| Adult | 2 | 1995 | 213712 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1995 | 12017 | 0.000 |
Why?
|
| Aged | 1 | 1993 | 162944 | 0.000 |
Why?
|
| Antigens | 1 | 1985 | 1462 | 0.000 |
Why?
|
| Antibodies | 1 | 1987 | 2459 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1984 | 2036 | 0.000 |
Why?
|
| Adolescent | 1 | 1995 | 85649 | 0.000 |
Why?
|